ARDX
Ardelyx, Inc. · Healthcare
Chief Development Officer David P. Rosenbaum sold $48K of Ardelyx, Inc.
Sold$47,684
$9.20Price
5,183Shares
−1%Stake
What ARDX did after the filing
- The stock from Wed, Feb 28 close, $9.46
- −22.1%
- S&P 500, same days
- +2.6%
Measured over 30 trading days, to the Apr 11 close.
Traded Mon, Feb 26. Filed Wed, Feb 28, 1:57 PM ET, during the session. Returns use the Feb 28 close and the Apr 11 close. Not investment advice.